Presence in the World’s Biggest Pharma Market
Schreiner MediPharm Launches Production Site in the USA
Schreiner MediPharm has successfully launched its new high-tech manufacturing location in Blauvelt in the state of New York. The launch was celebrated with an official opening ceremony. Besides North American pharmaceutical corporations, customers around the world will benefit from the additional capacities of the US plant as they are now being served by an even more extensive global production and distribution network.
By opening this additional manufacturing location Schreiner MediPharm responds to the growing demand for innovative specialty labels around the globe and particularly in the USA. The plant in Blauvelt rigorously meets Schreiner MediPharm’s high quality standards. This guarantees to pharmaceutical corporations with international activities that all products delivered to them have been manufactured according to the same quality standards, irrespective of the production location.
“The new production location in the USA is a milestone for Schreiner MediPharm. It marks a further step in our continual expansion as a globally active, highly capable partner of our customers,” said Roland Schreiner, who has worldwide responsibility for Schreiner MediPharm, during his speech at the opening ceremony in Blauvelt.
For further information, contact:
Schreiner MediPharm, a business unit of
Schreiner Group GmbH & Co. KG
Bruckmannring 22
85764 Oberschleissheim
Germany
Phone +49 89 31584-5400
Fax +49 89 31584-5422
info@schreiner-medipharm.com